First Horizon Advisors, Inc. Repligen Corp Transaction History

First Horizon Advisors, Inc.

$3.81 Billion
Q2 2025

A detailed history of First Horizon Advisors, Inc. transactions in Repligen Corp stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 761 shares of RGEN stock, worth $115,953. This represents 0.0% of its overall portfolio holdings.

Number of Shares

761

Previous 772 1.42%

Holding current value

$115,953

Previous $98,000 4.08%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$108.89 - $145.23 $1,197 - $1,597	-11 Reduced 1.42%	761 $94,000
Q4 2024 Feb 03, 2025	BUY	$123.41 - $160.92 $3,949 - $5,149	32 Added 4.32%	772 $111,000
Q3 2024 Nov 08, 2024	BUY	$119.79 - $167.35 $4,671 - $6,526	39 Added 5.56%	740 $110,000
Q2 2024 Jul 19, 2024	BUY	$120.0 - $182.95 $9,000 - $13,721	75 Added 11.98%	701 $88,000
Q1 2024 Apr 26, 2024	SELL	$170.78 - $208.42 $4,269 - $5,210	-25 Reduced 3.84%	626 $115,000
Q4 2023 Feb 06, 2024	SELL	$114.17 - $185.35 $2,740 - $4,448	-24 Reduced 3.56%	651 $117,000
Q3 2023 Oct 27, 2023	BUY	$138.78 - $176.51 $12,073 - $15,356	87 Added 14.8%	675 $107,000
Q2 2023 Aug 03, 2023	BUY	$138.42 - $180.31 $692 - $901	5 Added 0.86%	588 $83,000
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $16,660 - $21,394	-108 Reduced 15.63%	583 $98,000
Q4 2022 Feb 10, 2023	BUY	$162.42 - $220.56 $4,872 - $6,616	30 Added 4.54%	691 $116,000
Q3 2022 Nov 09, 2022	SELL	$160.42 - $256.21 $18,127 - $28,951	-113 Reduced 14.6%	661 $123,000
Q2 2022 Aug 02, 2022	BUY	$140.68 - $188.02 $103,540 - $138,382	736 Added 1936.84%	774 $125,000
Q1 2022 May 10, 2022	SELL	$161.19 - $257.96 $107,352 - $171,801	-666 Reduced 94.6%	38 $7,000
Q4 2021 Feb 09, 2022	BUY	$247.59 - $304.47 $11,389 - $14,005	46 Added 6.99%	704 $186,000
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $80,634 - $134,222	-414 Reduced 38.62%	658 $190,000
Q3 2021 Nov 09, 2021	BUY	$194.77 - $324.21 $136,144 - $226,622	699 Added 187.4%	1,072 $309,000
Q2 2021 Aug 09, 2021	BUY	$165.87 - $220.95 $331 - $441	2 Added 0.54%	373 $74,000
Q1 2021 May 11, 2021	SELL	$180.37 - $226.26 $3,066 - $3,846	-17 Reduced 4.38%	371 $72,000
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $2,961 - $4,131	20 Added 5.43%	388 $74,000
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $6,248 - $8,071	-51 Reduced 12.17%	368 $54,000
Q2 2020 Jul 31, 2020	BUY	$94.33 - $140.48 $18,488 - $27,534	196 Added 87.89%	419 $51,000
Q1 2020 May 05, 2020	BUY	$84.96 - $109.14 $11,214 - $14,406	132 Added 145.05%	223 $21,000
Q3 2019 Oct 23, 2019	BUY	$76.65 - $95.51 $6,975 - $8,691	91 New	91 $6,000

Others Institutions Holding RGEN

# of Institutions

513

Shares Held

54.7M

Call Options Held

223K

Put Options Held

673K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.46B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Repligen Corp Transaction History